Skip to content

The Effect of a Continuous 1-Hour Time Delay on Circadian Rhythms

The Effect of a Continuous 1-Hour Time Delay on Circadian Rhythms

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07317349
Enrollment
40
Registered
2026-01-05
Start date
2025-12-20
Completion date
2027-08-30
Last updated
2026-01-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Circadian Rhythms, Sleep, Time Perception

Keywords

circadian phase delay, Healthy adults

Brief summary

The purpose of this study is to investigate whether the experience of a daily time delay can affect our internal circadian rhythm.

Interventions

BEHAVIORALFixed daily routine

All activities occur at the same time every day

BEHAVIORALDaily time delay

All activities will be delayed by one hour per day over a 5 day period.

Sponsors

University of Aarhus
Lead SponsorOTHER
Independent Research Fund Denmark
CollaboratorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE

Masking description

Open-label, single-group basic science study; no masking used.

Intervention model description

Participating couples will need to live in this environment for 5 consecutive days. By lottery draw, you as a couple will either be exposed to a fixed daily routine, where all activities occur at the same time every day, or a daily time delay of 1 hour, where all activities will be delayed by one hour.

Eligibility

Sex/Gender
ALL
Age
23 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy adults aged 23-45 years * Part of a heterosexual, cohabiting couple willing to participate together in a five-day in-laboratory study * Both partners meet all inclusion criteria * Completion of at least upper-secondary education * Maintain a regular sleep-wake schedule * Habitual sleep timing within a normative range (non-extreme chronotype), assessed using the Morningness-Eveningness Questionnaire (MEQ) or the Munich Chronotype Questionnaire (MCTQ) * Both partners fall within the acceptable chronotype range to ensure aligned sleep-wake patterns * Low seasonality scores on the Seasonal Pattern Assessment Questionnaire (SPAQ) * Free from underlying sleep or mood disorders

Exclusion criteria

* Engages in night-shift work or maintains an irregular work or sleep schedule * International travel involving a time-zone change of more than two hours within the past two months, or anticipated travel before study completion * Diagnosed neurological, psychiatric, or sleep disorder (e.g., insomnia, sleep apnea, bipolar disorder) * High risk of sleep apnea, defined as a Berlin Questionnaire score \>2 (Lauritzen et al., 2018) * Use of medications known to affect sleep, alertness, melatonin secretion, or circadian timing * Unable or unwilling to comply with behavioral restrictions, including refraining from electronic devices displaying time cues unless clocks are removed and devices are disconnected from Wi-Fi * Unable or unwilling to comply with consumption restrictions, including abstaining from caffeine, alcohol, and melatonin-rich foods during the study * Extreme chronotype, defined as a habitual midsleep time outside 03:00-05:00 on the MCTQ or classification as an extreme morning or extreme evening type on the MEQ * Daily caffeine consumption exceeding 400 mg (approximately 4-5 cups of coffee) * Current smoker or smoking within the past six months

Design outcomes

Primary

MeasureTime frameDescription
Phase shift in circadian rhythm markersComparing samples on days 1, 3, 5The primary outcome is the timing of dim light melatonin onset, a marker of circadian phase. Saliva samples will be collected at regular intervals under dim light, and the time when melatonin exceeds 3 pg/mL will be recorded for each participant. This allows measurement of circadian phase shifts across conditions.

Secondary

MeasureTime frameDescription
Psychomotor Vigilance Task (PVT) Median Reaction TimePerformance will be measured at regular intervals on days 1 - 5 to track changes over the course of the study.Median reaction time (milliseconds) on a brief psychomotor vigilance task (PVT) six times each day. Participants respond as quickly as possible to visual stimuli presented at random inter-stimulus intervals. For each block, the median reaction time is computed; additional indices such as lapses (responses \> 500 ms) may be derived. Changes in PVT performance across the the 5 days are analysed in relation to circadian phase.

Countries

Denmark

Contacts

CONTACTAli Amidi, PhD
ali@psy.au.dk+4587165305
CONTACTAlisha Guyett, PhD
alisha.guyett@psy.au.dk

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026